Log in
OTCMKTS:IPCIF

IntelliPharmaCeutics Intl Stock Forecast, Price & News

$0.13
0.00 (0.00 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.13
Now: $0.13
$0.13
50-Day Range
$0.13
MA: $0.14
$0.16
52-Week Range
$0.06
Now: $0.13
$0.95
Volume31,030 shs
Average Volume112,017 shs
Market Capitalization$3.08 million
P/E RatioN/A
Dividend YieldN/A
Beta1.78
IntelliPharmaCeutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada. It develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Oxycodone ER, an abuse deterrent oxycodone hydrochloride extended release tablets; Regabatin and Lyrica pregabalin extended-release capsules for the management of neuropathic pain; Effexor XR, an extended-release capsule for oral administration to treat depression; Protonix, a delayed-release capsule for oral administration to treat gastroesophageal reflux disease; and Glucophage XR, a drug that treats type 2 diabetes. It also provides Seroquel XR, an oral psychotropic agent for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; Lamictal XR, an anticonvulsant drug to terat epilepsy; Keppra XR, an antiepileptic drug for the treatment of partial onset seizures in patients with epilepsy; Pristiq, a selective serotonin and norepinephrine reuptake inhibitor to treat major depressive disorder; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. In addition, the company provides Focalin XR, an extended-release capsule for hyperactivity disorder. It has has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.
Read More
IntelliPharmaCeutics Intl logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IPCIF
CUSIPN/A
Phone416-798-3001

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.48 million
Book Value($0.17) per share

Profitability

Net Income$-8,090,000.00
Net Margins-206.97%

Miscellaneous

EmployeesN/A
Market Cap$3.08 million
Next Earnings Date10/9/2020 (Estimated)
OptionableOptionable
$0.13
0.00 (0.00 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IPCIF News and Ratings via Email

Sign-up to receive the latest news and ratings for IPCIF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











IntelliPharmaCeutics Intl (OTCMKTS:IPCIF) Frequently Asked Questions

How has IntelliPharmaCeutics Intl's stock price been impacted by COVID-19?

IntelliPharmaCeutics Intl's stock was trading at $0.1201 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IPCIF stock has increased by 8.2% and is now trading at $0.13.
View which stocks have been most impacted by COVID-19
.

When is IntelliPharmaCeutics Intl's next earnings date?

IntelliPharmaCeutics Intl is scheduled to release its next quarterly earnings announcement on Friday, October 9th 2020.
View our earnings forecast for IntelliPharmaCeutics Intl
.

How were IntelliPharmaCeutics Intl's earnings last quarter?

IntelliPharmaCeutics Intl Inc (OTCMKTS:IPCIF) released its quarterly earnings results on Wednesday, July, 15th. The company reported ($0.04) EPS for the quarter. The company earned $0.40 million during the quarter.
View IntelliPharmaCeutics Intl's earnings history
.

When did IntelliPharmaCeutics Intl's stock split? How did IntelliPharmaCeutics Intl's stock split work?

IntelliPharmaCeutics Intl's stock reverse split before market open on Friday, September 14th 2018. The 1-10 reverse split was announced on Thursday, September 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 13th 2018. An investor that had 100 shares of IntelliPharmaCeutics Intl stock prior to the reverse split would have 10 shares after the split.

Are investors shorting IntelliPharmaCeutics Intl?

IntelliPharmaCeutics Intl saw a decline in short interest in the month of August. As of August 14th, there was short interest totaling 1,300 shares, a decline of 56.7% from the July 30th total of 3,000 shares. Based on an average daily volume of 64,300 shares, the short-interest ratio is presently 0.0 days.
View IntelliPharmaCeutics Intl's Short Interest
.

Who are some of IntelliPharmaCeutics Intl's key competitors?

Who are IntelliPharmaCeutics Intl's key executives?

IntelliPharmaCeutics Intl's management team includes the following people:
  • Dr. Isa Odidi, Co-Founder, Chairman, CEO & Co-Chief Scientific Officer (Age 61)
  • Dr. Amina Odidi, Pres, COO, Co-Chief Scientist Officer & Director (Age 59)
  • Mr. Greg Powell, Chief Financial Officer

What is IntelliPharmaCeutics Intl's stock symbol?

IntelliPharmaCeutics Intl trades on the OTCMKTS under the ticker symbol "IPCIF."

How do I buy shares of IntelliPharmaCeutics Intl?

Shares of IPCIF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is IntelliPharmaCeutics Intl's stock price today?

One share of IPCIF stock can currently be purchased for approximately $0.13.

How big of a company is IntelliPharmaCeutics Intl?

IntelliPharmaCeutics Intl has a market capitalization of $3.08 million and generates $3.48 million in revenue each year.

What is IntelliPharmaCeutics Intl's official website?

The official website for IntelliPharmaCeutics Intl is www.intellipharmaceutics.com.

How can I contact IntelliPharmaCeutics Intl?

IntelliPharmaCeutics Intl's mailing address is 30 WORCESTER ROAD, TORONTO A6, M9W 5X2. The company can be reached via phone at 416-798-3001 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.